Stoke Therapeutics Inc (NASDAQ:STOK)

18.12
Delayed Data
As of Jan 21
 -0.02 / -0.11%
Today’s Change
17.71
Today|||52-Week Range
69.52
-24.47%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Ticho Barry S
Chief Medical Officer
Sale7/13/202139,866$32.68$1.3M-44.61%
Tulipano Stephen J
Chief Financial Officer
Sale2/22/202115,202$58.67$891.9K-69.01%
Tzianabos Arthur O
Director
Sale2/19/202110,000$60.67$606.7K-70.26%
Tulipano Stephen J
Chief Financial Officer
Sale2/22/20219,696$59.29$574.9K-69.01%
Levin Arthur A
Director
Sale3/01/20217,543$60.55$456.7K-70.40%
Levin Arthur A
Director
Sale3/01/20214,957$61.14$303.1K-70.40%
Tulipano Stephen J
Chief Financial Officer
Sale2/23/20215,000$58.60$293.0K-69.46%
Nash Huw M
Sale7/01/20215,700$33.33$190.0K-46.89%
Liau Gene
Sale3/02/20212,900$63.52$184.2K-69.83%
Nash Huw M
Sale8/02/20215,700$28.87$164.6K-37.28%
Page of 4